Accessibility Menu
Todos Medical logo

Todos Medical

(OTC) TOMDF

Current Price$0.00
Market Cap$1.40KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2017)-100%
5 Year-100%
1 Year+0%
1 Month+0%

Todos Medical Financials at a Glance

Market Cap

$1.40KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$7.70M

Net Income (TTM)

-$26.75M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

1.69 (High)

Price

$0.00

Volume

18,906

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

TOMDF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Todos Medical

Industry

Biotechnology

Employees

23

CEO

Gerald E. Commissiong

Headquarters

Tel Aviv, TA 6701203, IL

TOMDF Financials

Key Financial Metrics (TTM)

Gross Margin

56.01%

Operating Margin

-126.68%

Net Income Margin

-324.81%

Return on Equity

83.70%

Return on Capital

-343.72%

Return on Assets

-163.71%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.40KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.41B

Volume

18.91K

Avg. Volume

17.10K

Financials (TTM)

Gross Profit

$4.08M

Operating Income

-$8.99M

EBITDA

-$7.45M

Operating Cash Flow

-$2.67M

Capital Expenditure

$1.61M

Free Cash Flow

-$1.06M

Cash & ST Invst.

$34.00K

Total Debt

$38.35M

Todos Medical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2022YOY CHG

Revenue

$1.40M

-68.5%

Gross Profit

$1.40M

-22.1%

Gross Margin

100.00%

N/A

Market Cap

$1.40KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$200.00

N/A

Employees

7

N/A

Net Income

-$4.99M

+73.4%

EBITDA

-$1.88M

+75.8%

Quarterly Fundamentals

Name
Q4 2022YOY CHG

Total Cash

$34.00K

-82.0%

Total Debt

$38.35M

+20.8%

Accounts Receivable

$1.05M

-58.4%

Inventory

$1.02M

-36.3%

Long Term Debt

$33.05M

+11.2%

Short Term Debt

$5.30M

+162.0%

Return on Assets

-1.64%

N/A

Return on Invested Capital

7.49%

N/A

Free Cash Flow

$883.90K

+143.0%

Operating Cash Flow

-$796.96K

+58.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NEPTFNeptune Wellness Solutions Inc.
$0.00+0.00%
ACUSAcusphere, Inc.
$0.00+0.00%
BIOAFBioasis Technologies Inc.
$0.00+0.00%
SCRCQScripsAmerica, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$16.95-0.01%
PATHUiPath
$11.68-0.01%
FRMIFermi
$6.59-0.10%
ONDSOndas
$7.26-0.05%

Questions About TOMDF

What is the current price of Todos Medical?

Todos Medical is trading at $0.00 per share.

What is the 52-week range for Todos Medical?

Over the past 52 weeks, Todos Medical has traded between $0.00 and $0.00.

How much debt does Todos Medical have?

As of the most recent reporting period, Todos Medical reported total debt of $38.35M.

How much cash does Todos Medical have on hand?

Todos Medical reported $34.00K in cash and cash equivalents in its most recent financial results.

What is Todos Medical’s dividend yield?

Todos Medical does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.